semaglutide cardiovascular outcomes study news and in Patients with Type 2 Diabetes Semaglutide and Cardiovascular Outcomes in

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

Efficacy in Weight Loss and Glycemic Control: GLP-1 receptor agonists not only help regulate blood sugar levels but also aid in weight loss, making them a highly sought-after solution in both diabetes and obesity management

doi:10.1093/oxfordjournals.humrep.a019708 Lenzi A, Lombardo F, Gandini L, Culasso F, Dondero F

Blood Sugar and Metabolic Benefits For tirzepatide at low doses, glucose control improved significantly across fasting and post-meal measurements. Markers of pancreatic function showed substantial improvement, suggesting GLP-1s protect the cells that produce insulin. This could explain why metabolic benefits last beyond treatment

Never make up for a missed dose by taking a double dose